Stelac Advisory Services LLC Apellis Pharmaceuticals, Inc. Transaction History
Stelac Advisory Services LLC
- $249 Million
- Q4 2024
A detailed history of Stelac Advisory Services LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Stelac Advisory Services LLC holds 5,520 shares of APLS stock, worth $138,220. This represents 0.07% of its overall portfolio holdings.
Number of Shares
5,520
Previous 5,520
-0.0%
Holding current value
$138,220
Previous $159,000
10.69%
% of portfolio
0.07%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$306 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$298 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$295 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$252 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$241 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.75B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...